Loading company
Cryoport, Inc.
CYRX · Nasdaq · Industrials · Integrated Freight and Logistics
Next earnings: November 3, 2026
$17.31-0.5%Sep 29 close
- 1M
- +7.6%
- 6M
- +119.4%
- 1Y
- +82.6%
- 5Y
- -75.3%
CYRX · Nasdaq · Industrials · Integrated Freight and Logistics
Next earnings: November 3, 2026
$17.31-0.5%Sep 29 close
Cryoport, Inc. is scheduled to report next on November 3, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $49M | $45.5M | +7.74% |
| Profit | -$8.3M | $108.9M | -107.58% |
| Profit per share | -$0.20 | $2.13 | -109.39% |
| Free Cash Flow | -$8M | -$11.7M | +31.84% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Releases land after the close or before the open, so the move is the session that follows.
Cryoport, Inc . (Nasdaq: CYRX) is a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, with an emphasis on regenerative medicine. We support biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products designed to minimize risk and maximize reliability across the temperature-controlled supply chain for the life sciences. Our integrated supply chain platform includes the Cryoportal ® Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized BioLogistics, BioStorage, BioServices, cryopreservation services, and cryogenic systems, which in varying combinations deliver end-to-end solutions that meet the rigorous demands of the life sciences. With innovation, regulatory compliance, and agility at our core, we are "Enabling the Future of Medicine™." Headquartered in Nashville, Tennessee, our company maintains a strong global presence with operations across the Americas, EMEA, and APAC.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Cryoport, Inc.’s Item 2.02 8-K filed August 6, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Cryoport, Inc. has no earnings call transcript available.